Skip to main content

Mitsubishi UFJ Asset Management Co., Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1466546 TOKYO, M0

Position in NBIX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$14,631,307
+$416,821 QoQ
Shares Held
111,062
+10.8% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Mitsubishi UFJ Asset Management Co., Ltd. holds $601,157,749 across 14 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
111,062 $14,631,307

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,631,307 111,062
2025-12-31 $14,214,486 100,222
2025-09-30 $12,723,481 90,636
2025-06-30 $11,486,557 91,388
2025-03-31 $8,507,573 76,922
2024-12-31 $10,499,853 76,922
2024-09-30 $7,816,063 67,836
2024-06-30 $8,865,672 64,398
2024-03-31 $7,612,356 55,194
2023-12-31 $5,425,745 41,179
2023-09-30 $4,629,487 41,151
2023-06-30 $3,872,523 41,066
2023-03-31 $3,537,942 34,953
2022-12-31 $3,660,477 30,647
2022-09-30 $2,928,953 27,577
2022-06-30 $2,692,397 27,620
2022-03-31 $2,207,531 23,547
2021-12-31 $2,030,537 23,841
2021-09-30 $2,032,524 21,192
2021-06-30 $2,027,856 20,837
2021-03-31 $1,792,123 18,428
2020-12-31 $1,635,201 17,060
2020-09-30 $1,556,926 16,191
2020-06-30 $1,719,834 14,097
2020-03-31 $1,127,573 13,028